Literature DB >> 15096700

Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species.

Gemma Casadesus1, Mark A Smith, Xiongwei Zhu, Gjumrakch Aliev, Adam D Cash, Kazuhiro Honda, Robert B Petersen, George Perry.   

Abstract

Free radical formation, abnormalities in iron and copper distribution, and metal-catalyzed oxidation have all been noted in Alzheimer disease and are thought to play an important role in disease pathogenesis. Metal-catalyzed hydroxyl radical formation results in damage to every category of macromolecule found in the vulnerable neuronal populations in Alzheimer disease. In fact, redox activity resides within the cytosol of vulnerable neurons. Since oxidative damage represents one of the earliest pathological changes in Alzheimer disease, it is likely that aberrant redox activity is among the earliest changes in the transition to the disease state. In this review, we consider the wealth of evidence implicating a central role for metals in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096700     DOI: 10.3233/jad-2004-6208

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  38 in total

1.  β-Asarone Mitigates Amyloidosis and Downregulates RAGE in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Cong Yang; Xiaoguang Li; Yousheng Mo; Sijun Liu; Luguang Zhao; Xiaohui Ma; Zhigang Fang; Junli Chen; Yunbo Chen; Xuhua Yu; Shuhuan Fang; Yongbin Zhang; Shaoxiang Xian; Qi Wang
Journal:  Cell Mol Neurobiol       Date:  2015-08-14       Impact factor: 5.046

Review 2.  Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.

Authors:  Xiongwei Zhu; George Perry; Mark A Smith; Xinglong Wang
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.

Authors:  Gang Liu; Ping Men; Wataru Kudo; George Perry; Mark A Smith
Journal:  Neurosci Lett       Date:  2009-03-25       Impact factor: 3.046

4.  Aβ association inhibition by transferrin.

Authors:  Annie V Raditsis; Julijana Milojevic; Giuseppe Melacini
Journal:  Biophys J       Date:  2013-07-16       Impact factor: 4.033

5.  Nanoparticle and iron chelators as a potential novel Alzheimer therapy.

Authors:  Gang Liu; Ping Men; George Perry; Mark A Smith
Journal:  Methods Mol Biol       Date:  2010

6.  Serum ferritin is a candidate biomarker of disease aggravation in amyotrophic lateral sclerosis.

Authors:  Jixu Yu; Nian Wang; Faying Qi; Xianjun Wang; Qiyi Zhu; Yucheng Lu; Huiling Zhang; Fengyuan Che; Wei Li
Journal:  Biomed Rep       Date:  2018-08-02

Review 7.  Oxidative stress signaling in Alzheimer's disease.

Authors:  B Su; X Wang; A Nunomura; P I Moreira; H-gon Lee; G Perry; M A Smith; X Zhu
Journal:  Curr Alzheimer Res       Date:  2008-12       Impact factor: 3.498

Review 8.  Antioxidant therapy in Alzheimer's disease: theory and practice.

Authors:  Gjumrakch Aliev; Mark E Obrenovich; V Prakash Reddy; Justin C Shenk; Paula I Moreira; Akihiko Nunomura; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Mini Rev Med Chem       Date:  2008-11       Impact factor: 3.862

9.  Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.

Authors:  Gang Liu; Ping Men; George Perry; Mark A Smith
Journal:  J Nanoneurosci       Date:  2009-06-01

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.